Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPV/r + RAL vs EFV/TDF/FTC in HIV-Naïve Patients
NCT00752856Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Aug 2008
- Primary completion
- May 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of raltegravir, lopinavir, ritonavir in human immunodeficiency virus infection (HIV), sponsored by University of California, San Diego. Started Aug 2008; status: completed.
02
Drugs
raltegravirlopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00752856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752856.